captopril has been researched along with spirapril in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baum, T; Gold, EH; McNamara, P; Neustadt, BR; Smith, EM; Swiss, GF; Sybertz, EJ | 1 |
Cushman, DW; DeForrest, JM; Duggan, M; Karanewsky, DS; Krapcho, J; Powell, JR; Rovnyak, G; Schwartz, J; Spitzmiller, ER; Turk, C | 1 |
de Graeff, PA; de Langen, CD; Pinto, YM; van Gilst, WH; van Wijngaarden, J; Wesseling, H | 1 |
Forlani, A; Guzzon, V; Lazzaroni, A; Milani, S; Monopoli, A | 1 |
de Graeff, PA; Girbes, AR; Hillege, H; Lie, KI; Smit, AJ; van den Broek, SA; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
de Graeff, PA; Hillege, H; Lie, KI; van den Broek, SA; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
Aliev, FR; Isaeva, BG; Kraĭsman, VA; Polimbetov, DS | 1 |
2 trial(s) available for captopril and spirapril
Article | Year |
---|---|
Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Circulation; Captopril; Cerebrovascular Circulation; Double-Blind Method; Enalapril; Exercise Test; Female; Heart Failure; Humans; Leg; Liver Circulation; Male; Middle Aged; Peptidyl-Dipeptidase A; Regional Blood Flow; Renal Circulation | 1995 |
Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Captopril; Double-Blind Method; Enalapril; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Renin | 1997 |
6 other study(ies) available for captopril and spirapril
Article | Year |
---|---|
Angiotensin converting enzyme inhibitors: spirapril and related compounds.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Chemical Phenomena; Chemistry; Dogs; Enalapril; Male; Phenylbutyrates; Rats; Rats, Inbred Strains; Spiro Compounds | 1989 |
Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Enalapril; Enalaprilat; Kinetics; Male; Phosphinic Acids; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1988 |
Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Enalapril; Heart; Heart Rate; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains | 1991 |
Antihypertensive activity of a new ACE-inhibitor, SCH 33844, during repeated administration in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Dose-Response Relationship, Drug; Enalapril; Male; Rats; Rats, Inbred SHR; Substance Withdrawal Syndrome | 1987 |
[Efficacy of quadropril (spirapril) vs capropril in treatment of essential hypertension].
Topics: Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Captopril; Enalapril; Female; Heart Ventricles; Humans; Hypertension; Middle Aged; Myocardial Contraction; Prognosis; Severity of Illness Index; Ultrasonography; Vascular Resistance | 2000 |
[Hypertensive patient with diabetes. "Blood pressure cosmetics" are not enough here].
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Diabetes Mellitus, Type 2; Enalapril; Evidence-Based Medicine; Humans; Hypertension; Treatment Outcome | 2002 |